Related Experiment Videos
Tuberculous meningitis in childhood. Forty-three cases
Insights
Early diagnosis and treatment of pediatric tuberculous meningitis (TBM) with adrenocorticosteroids improve outcomes. While many patients recover, neurological sequelae are common, highlighting the need for timely intervention in TBM cases.
Area of Science:
- Pediatrics
- Infectious Diseases
- Neurology
Background:
- Tuberculous meningitis (TBM) is a severe infection affecting the central nervous system.
- Pediatric TBM presents significant diagnostic and therapeutic challenges.
- Adrenocorticosteroids are used as adjunctive therapy in TBM management.
Purpose of the Study:
- To evaluate the prognosis of pediatric tuberculous meningitis.
- To assess the impact of adrenocorticosteroid therapy on TBM outcomes.
- To determine the relationship between disease stage at admission and neurological sequelae.
Main Methods:
- Retrospective analysis of 43 pediatric patients diagnosed with tuberculous meningitis.
- Review of treatment protocols, including the use of adrenocorticosteroids.
- Assessment of patient outcomes, including mortality, recovery, and neurological sequelae based on initial disease stage.
Main Results:
- Out of 43 pediatric patients, 8 died, 23 recovered with late neurological sequelae, and 12 recovered without gross neurological sequelae.
- Recovery without sequelae was highest in stage 1 (4/4 patients), followed by stage 2 (7/33 patients), and stage 3 (1/6 patients).
- The overall prognosis was significantly influenced by the stage of the disease at the time of hospital admission.
Conclusions:
- Early diagnosis and prompt initiation of appropriate treatment are critical for improving the prognosis of pediatric tuberculous meningitis.
- Adrenocorticosteroid therapy may contribute to better outcomes, but late neurological sequelae remain a significant concern.
- Disease staging at presentation is a key factor in predicting recovery and the likelihood of neurological deficits in pediatric TBM.
Abstract:
Forty-three patients in the pediatric age group had tuberculous meningitis. Therapy included the use of adrenocorticosteroids. All four patients who were in stage 1 on admission to the hospital, seven of the 33 in stage 2, and one of the six in stage 3 (coma) recovered without gross neurological sequelas. Eight patients died, and the remaining 23 recovered, with late neurological sequelas. Early diagnosis and appropriate treatment determine the prognosis of tuberculous meningitis.